Treatment of limited disease small cell lung cancer: the multidisciplinary team

Markus Glatzer; Achim Rittmeyer; Joachim Müller; Isabelle Opitz; Alexandros Papachristofilou; Ioannis Psallidas; Martin Früh; Diana Born; Paul Martin Putora

doi:10.1183/13993003.00422-2017

Treatment of limited disease small cell lung cancer: the multidisciplinary team

Eur Respir J. 2017 Aug 24;50(2):1700422. doi: 10.1183/13993003.00422-2017. Print 2017 Aug.

Authors

Markus Glatzer¹, Achim Rittmeyer², Joachim Müller³, Isabelle Opitz⁴, Alexandros Papachristofilou⁵, Ioannis Psallidas^{6

7}, Martin Früh⁸, Diana Born⁹, Paul Martin Putora¹⁰

Affiliations

¹ Dept of Radiation Oncology, Kantonsspital St Gallen, St Gallen, Switzerland [email protected].
² Dept of Thoracic Oncology, Lungenfachklinik Immenhausen, Immenhausen, Germany.
³ Dept of Radiology and Nuclear Medicine, Kantonsspital St Gallen, St Gallen, Switzerland.
⁴ Dept of Thoracic Surgery, University Hospital Zürich, Zürich, Switzerland.
⁵ Dept of Radiation Oncology, University Hospital Basel, Basel, Switzerland.
⁶ Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, UK.
⁷ Oxford Respiratory Trials Unit, Churchill Hospital, Oxford, UK.
⁸ Dept of Oncology and Haematology, Kantonsspital St Gallen, St Gallen, Switzerland.
⁹ Institute of Pathology, Kantonsspital St Gallen, St Gallen, Switzerland.
¹⁰ Dept of Radiation Oncology, Kantonsspital St Gallen, St Gallen, Switzerland.

PMID: 28838979
DOI: 10.1183/13993003.00422-2017

Abstract

Small cell lung cancer (SCLC) presents multiple interdisciplinary challenges with several paradigm shifts in its treatment in recent years. SCLC treatment requires multidisciplinary management and timely treatment. The aim of this review is to focus on the team management aspects in the treatment of limited disease SCLC and how this can contribute towards improving outcomes.

Publication types

Review

MeSH terms

Humans
Lung Neoplasms* / pathology
Lung Neoplasms* / therapy
Patient Care Management / methods
Patient Care Team / organization & administration*
Small Cell Lung Carcinoma* / pathology
Small Cell Lung Carcinoma* / therapy
Time-to-Treatment
Treatment Outcome